The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology
Reference28 articles.
1. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial;Yarnold;Radiother Oncol – J Eur Soc Ther Radiol Oncol,2005
2. Cancer statistics, 2017;Siegel;Ca - Cancer J Clin,2017
3. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis;Kong;J Natl Cancer Inst,2012
4. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system;Grigsby;Int J Radiat Oncol Biol Phys,1992
5. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma;Creutzberg;Lancet,2000
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predictors of recurrence and survival in lymphovascular space invasion negative early-stage endometrioid endometrial cancer patients;Journal of the Turkish-German Gynecological Association;2023-12-01
2. Clinical outcomes and recurrence patterns of high‐intermediate‐risk and high‐risk early‐stage endometrial cancer treated with postoperative intracavitary brachytherapy;Precision Radiation Oncology;2023-09
3. Postoperative Adjuvant Treatment in Women with Stage I Endometrial Cancer: A Retrospective Study;International Journal of Clinical Practice;2023-03-31
4. Five-year disease-free survival in FIGO IA stage endometrial cancer patients: Tertiary institution experience in a developing country;Journal of Contemporary Brachytherapy;2023
5. Preoperative serum CA125 level and age at diagnosis: An effective prognosis prediction tool for patients with early‐stage endometrial cancer;Asia-Pacific Journal of Clinical Oncology;2022-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3